Healthcare

Oligonucleotide Synthesis Market to Rise to US$4.189 bn by the end of 2025

Press Release

Global Oligonucleotide Synthesis Market: Snapshot

Entry of new players in the global oligonucleotide synthesis market has heated up competition. Players wanting to grow their market shares have mostly resorted to cutting down prices to draw more customers. This has also put a downward pressure on prices and subsequently many prominent vendors have been forced to strategically cut down certain service and product arms and focus on a niche sector.

Currently, Thermo Fisher Scientific holds a dominant position in the global oligonucleotide synthesis market because of its diverse product portfolio and strong outreach. Sigma-Aldrich Corporation comes in the second position in terms of market share.

The global oligonucleotides synthesis market has been on a sustained growth trajectory on account of the rapidly growing biotechnology and life sciences sectors, coupled with the increasing uptake of the increasing applications of oligonucleotides in research and diagnostic fields. Pharmaceutical and biotechnology companies and research and diagnostic laboratories involved in drug discovery and development, along with diagnostic devices and tests, for the treatment of chronic diseases and oligonucleotides are also serving to stoke growth in the market.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11804

A report by Transparency Market Research forecasts the global oligonucleotide synthesis market to expand at a strong 11.2% CAGR from 2017 to 2025 to attain a value of US$4.189 bn by 2025 from US$1.65 bn in 2016.

Synthesized Oligonucleotides Lead Market on Account of Different Customizations Offered by Manufacturers

Depending upon the type of products, the global oligonucleotide synthesis market can be divided into reagents and consumables, equipment, and synthesized oligonucleotides. Among them, the synthesized oligonucleotides segment leads the market with a dominant share because of the increasing number of manufacturers offering various customizations and rising applications of ready to use synthesized oligonucleotides in therapeutics.

The two kinds of commercially used synthesized oligonucleotide are DNA oligonucleotides and RNA oligonucleotides. Locked Nucleic acid (LNA) and Bridged Nucleic Acid (BNA) are the other types of synthesized oligonucleotides that find application in research.

Presence of Numerous Small Companies Makes China Key Region in Asia Pacific 

From a geographical perspective, the global oligonucleotide synthesis market is dominated by North America. It is expected to retain its leading share, albeit decreasing it slightly, to account for 33.3% of the market. Strongly supporting growth in the North America market is the growing number of pharmaceutical companies leveraging oligonucleotides in therapeutics, research and diagnostics. Increasing number of genetic diseases in the region and the resultant demand for researchers to develop newer and advanced drugs to treat them is also expected to drive the market in the region.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11804

Europe is another key region in the global oligonucleotide synthesis market and by 2025, it is slated to account for 26.6% share in revenue in the market on the back of considerable thrust on developing newer and sophisticated technologies for building new molecules of oligonucleotides for therapeutic use. Start-up companies with new technologies and rich patent portfolios, are predicted to contribute to the market significantly.

In terms of growth rate, Asia Pacific will likely surpass all other regions by clocking a healthy 12.5% CAGR between 2017 and 2025. China is a major driver of growth in the region on account of being home to numerous of small companies providing reagents and consumables for oligonucleotide synthesis. Besides China, India and Japan are also major contributors to the market because of bettering health care infrastructure, increasing private and public investment in life sciences research, and diagnostics advancements in disease treatment.

Prominent participants in the global oligonucleotide synthesis market are Thermo Fisher Scientific, GE Healthcare, DNA Technologies, BioAutomation, Applied Biosystems, GeneDesign, Inc., Eurofins Genomics, Integrated Kaneka Eurogentec S.A., Sigma-Aldrich Corporation, and Agilent Technologies.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: www.transparencymarketresearch.com

Tags

Related Articles

Close